The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review

Value in Health Regional Issues
Ian F WalkerHelen Elsey

Abstract

More than 80% of global deaths caused by cardiovascular disease (CVD) and diabetes mellitus (DM) occur in developing countries. The burden of noncommunicable disease in South Asia is increasing rapidly. To estimate the costs of CVD and the costs of DM to individuals and society in Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka. We systematically searched six health and economic databases for studies identifying costs related to CVD or DM and their respective complications. Costs were extracted from included studies and converted to US $ for the price year 2015 to enable meaningful comparisons. Of the 71 articles suitable for full-text review, 29 studies met the inclusion criteria. Most were cost-of-illness studies (n = 27) and were from the patient perspective (n = 23). Most collected data since 2000 (n = 23) and included data from India (n = 24). No studies included longitudinal costs at the patient level. Medical costs for routine management of CVD and DM were broadly similar. These costs escalate significantly once complications occur, which require treatment, particularly for stroke, major coronary events, and amputations. Costs are mainly borne by the individual and family. Some included s...Continue Reading

References

Mar 8, 2000·Diabetes Research and Clinical Practice·R ShobhanaA Ramachandran
Feb 24, 2001·European Journal of Clinical Pharmacology·S MalhotraV K Bhargava
Nov 9, 2001·European Journal of Clinical Pharmacology·S MalhotraS Jain
Sep 1, 2006·PharmacoEconomics·Ebere AkobunduC Daniel Mullins
Nov 22, 2007·BMC Health Services Research·Liaquat A KhowajaPeter Cosgrove
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·S M AliZ Miyan
Jan 3, 2009·Diabetes Research and Clinical Practice·Shabana TharkarVijay Viswanathan
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Jun 12, 2010·Diabetes Research and Clinical Practice·Shabana TharkarVijay Viswanathan
May 25, 2011·PharmacoEconomics·Allison Larg, John R Moss
Sep 12, 2012·Health Economics Review·Nagede CostaLaurent Molinier
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Jan 21, 2014·Neurology India·Gagandeep KwatraJeyaraj D Pandian
Mar 13, 2014·Tropical Medicine & International Health : TM & IH·Anup KaranAjay Mahal
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Jul 6, 2014·Journal of Research in Pharmacy Practice·Sadanandam AkariBuchi Reddy Kunduru
Aug 15, 2014·Indian Journal of Nephrology·K SatyavaniV Viswanathan
Aug 16, 2014·The Cochrane Database of Systematic Reviews·Chunjie LiZipporah Iheozor-Ejiofor
Sep 6, 2014·British Medical Bulletin·Karen R SiegelMohammed K Ali
Dec 3, 2014·Globalization and Health·Charles A K YesudianAlessandra Ferrario
Feb 13, 2015·The Open Ophthalmology Journal·Pablo ChandraAmit Walimbe
Jun 1, 2013·Global Heart·Andrew Moran, Rajesh Vedanthan
Mar 20, 2015·PharmacoEconomics·Till SeuringMarc Suhrcke
Aug 19, 2015·Progress in Cardiovascular Diseases·Evan L O'KeefeCarl J Lavie
May 5, 2016·Circulation·Dorairaj PrabhakaranAmbuj Roy

❮ Previous
Next ❯

Citations

Mar 14, 2019·Journal of Diabetes·Anoop MisraKaushik L Ramaiya
Aug 18, 2020·Risk Management and Healthcare Policy·Shahla DarbaMahmood Yousefi
May 8, 2019·Health Research Policy and Systems·Rebecca DoddJacqui Webster
May 18, 2019·Current Diabetes Reports·Kavita SinghKaren Eggleston
Aug 14, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Shahid ShahAbid Shah
May 1, 2021·International Journal of Environmental Research and Public Health·Fiorella Pia SalvatoreMariantonietta Fiore
Oct 23, 2021·Diabetes Care·Khyati K BankerElla Zomer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.